MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
PBM — Psyence Biomedical Ltd. Common Shares
NasdaqPsyence Biomedical Ltd. Common Shares
$4.88
-0.14(-2.79%)
- O
- 4.93
- H
- 5.10
- L
- 4.84
- V
- 16.2K
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About PBM
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
IndustryCommon Stock
SectorNot available
IPO DateJan 26, 2024
Employees12
Stock ExchangeNasdaq
Ticker SymbolPBM
Websitehttps://www.psyence.com
Key Financial Statistics
| Market Cap | $19.68M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.92 - $175.78 |
| 52-Week Avg Volume | 728.7K |
| VWAP | $4.92 |
| Transactions | 257 |
| Total Recorded Bars | 1,210 days |